Thor AD - Search Results

1

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC.

Liu S, Polsdofer EV, Zhou L, Ruan S, Lyu H, Hou D, Liu H, Thor AD, He Z, Liu B. Liu S, et al. Among authors: thor ad. Mol Ther Oncolytics. 2021 Apr 29;21:303-314. doi: 10.1016/j.omto.2021.04.012. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 34141868 Free PMC article.

2

Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.

Liu B, Ordonez-Ercan D, Fan Z, Edgerton SM, Yang X, Thor AD. Liu B, et al. Among authors: thor ad. Int J Cancer. 2007 May 1;120(9):1874-82. doi: 10.1002/ijc.22423. Int J Cancer. 2007. PMID: 17266042 Free article.

3

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.

Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD. Alimova IN, et al. Among authors: thor ad. Cell Cycle. 2009 Mar 15;8(6):909-15. doi: 10.4161/cc.8.6.7933. Epub 2009 Mar 26. Cell Cycle. 2009. PMID: 19221498

4

Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD. Liu B, et al. Among authors: thor ad. Cell Cycle. 2009 Jul 1;8(13):2031-40. doi: 10.4161/cc.8.13.8814. Epub 2009 Jul 21. Cell Cycle. 2009. PMID: 19440038

5

Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.

Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD. Liu B, et al. Among authors: thor ad. Mol Cancer Res. 2009 Nov;7(11):1882-92. doi: 10.1158/1541-7786.MCR-08-0509. Epub 2009 Oct 27. Mol Cancer Res. 2009. PMID: 19861407

6

Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin.

Huang X, Gao L, Wang S, McManaman JL, Thor AD, Yang X, Esteva FJ, Liu B. Huang X, et al. Among authors: thor ad. Cancer Res. 2010 Feb 1;70(3):1204-14. doi: 10.1158/0008-5472.CAN-09-3321. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103628

7

Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions.

Liu B, Fan Z, Edgerton SM, Yang X, Lind SE, Thor AD. Liu B, et al. Among authors: thor ad. Cell Cycle. 2011 Sep 1;10(17):2959-66. doi: 10.4161/cc.10.17.16359. Epub 2011 Sep 1. Cell Cycle. 2011. PMID: 21862872

8

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.

Deng XS, Wang S, Deng A, Liu B, Edgerton SM, Lind SE, Wahdan-Alaswad R, Thor AD. Deng XS, et al. Among authors: thor ad. Cell Cycle. 2012 Jan 15;11(2):367-76. doi: 10.4161/cc.11.2.18813. Epub 2012 Jan 15. Cell Cycle. 2012. PMID: 22189713

9

Glucose promotes breast cancer aggression and reduces metformin efficacy.

Wahdan-Alaswad R, Fan Z, Edgerton SM, Liu B, Deng XS, Arnadottir SS, Richer JK, Anderson SM, Thor AD. Wahdan-Alaswad R, et al. Among authors: thor ad. Cell Cycle. 2013 Dec 15;12(24):3759-69. doi: 10.4161/cc.26641. Epub 2013 Oct 3. Cell Cycle. 2013. PMID: 24107633 Free PMC article.

10

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.

Wang S, Huang J, Lyu H, Cai B, Yang X, Li F, Tan J, Edgerton SM, Thor AD, Lee CK, Liu B. Wang S, et al. Among authors: thor ad. Breast Cancer Res. 2013;15(5):R101. doi: 10.1186/bcr3563. Breast Cancer Res. 2013. PMID: 24168763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page